Identification of HM13 as a prognostic indicator and a predictive biomarker for immunotherapy in hepatocellular carcinoma. Zhang G, Lv X, Yang Q, Liu H, et al. BMC Cancer 2022;22:888.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhang G, Lv X, Yang Q, Liu H, et al. Identification of HM13 as a prognostic indicator and a predictive biomarker for immunotherapy in hepatocellular carcinoma. BMC Cancer 2022;22:888.
PMID: 35964022